Owner Scorecard


← All companies ← H Manual HAFC → ← GMED Medical Devices & Equipment HOLX →

HAE, Haemonetics

Medical Devices & Equipment consumer brand Serial acquirer

Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care.

Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components.

For that purpose, "Plasma" includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers.

Latest annual: FY2026 10-K
HAE · Haemonetics
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2026
$1.3B
−2.0% YoY · 9% 5-yr CAGR
Vital signs · TTM, with 5-yr average
Revenue $1.3B 5-yr avg $1.2B
Gross margin 59% 5-yr avg 54%
Operating margin 11.7% 5-yr avg 12.4%
ROIC 7% 5-yr avg 8%
Owner-earnings margin 20% 5-yr avg 13%
Free cash flow margin 20% 5-yr avg 11%

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

What it is
Revenue is Hospital (44%), Plasma (39%) and Blood Center (17%).
Situation
Serial acquirer. Goodwill and acquired intangibles are 46% of assets, with meaningful acquisition spending in 4 of the record's 10 years; much of what this business is was bought, at prices the record carries.
What moves the needle
Gross margin has run about 49% and operating margin about 10% through the cycle, a solid spread between what it charges and what the product costs to make. The operating margin has swung widely — from −2.2% to 16% over the years — so the through-cycle figure carries more than any single year, and the worst year more than the best. Inventory runs near 23% of sales, so how fast it turns back into cash — and the risk of writing it down when demand softens — sits alongside the margin. Read this kind of business on the installed base and what follows it. On its own account, the filing leans hardest on customer concentration, set against the numbers in what the filing emphasizes, below.
Is it a good business?
Return on capital has sat near the cost of capital (median 7%). By owner earnings: roughly 11% of revenue reaches owners as cash, consistently. This is price-taker territory, where the balance sheet and the cycle matter more than any multiple; the rest is in the 10-K.

Every line is arithmetic on the company's filings, shown in full in the sections below.

Where the money comes from

read the 10-K →

Revenue spreads across 3 segments, the largest Hospital at 44%.

Revenue by reportable segment, FY2026
  • Hospital44%$588M
  • Plasma39%$524M
  • Blood Center17%$221M
By geographyUnited States74%Europe14%Asia7%Japan5%Other1%

From the segment footnote of the company's own 10-K. Shares are of total revenue; the profit bar shows each segment's share of segment operating profit, before unallocated corporate costs.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2017–2026

realized figures from each filing · older years to the left
2017’172018’182019’192020’202021’212022’222023’232024’242025’252026’26TTMTTMMar 2026
Income statement
$886M$904M$968M$988M$870M$993M$1.2B$1.3B$1.4B$1.3B$1.3BRevenueRevenue
43%46%43%49%46%51%53%53%55%59%59%Gross marginGross mgn
34%35%28%29%32%34%32%33%32%33%33%SG&A / revenueSG&A/rev
4%4%4%3%4%5%4%4%5%4%4%R&D / revenueR&D/rev
($19M)$56M$84M$103M$90M$81M$156M$165M$222M$157M$157MOperating incomeOp. inc.
−2.2%6.2%8.6%10.5%10.3%8.1%13.4%12.6%16.3%11.7%11.7%Operating marginOp. mgn
($26M)$46M$55M$77M$79M$43M$115M$118M$168M$97M$97MNet incomeNet inc.
24%25%12%-9%32%18%23%21%24%24%Effective tax rateTax rate
Cash flow & returns
$160M$220M$159M$158M$109M$172M$273M$182M$182M$293M$293MOperating cash flowOp. cash
$90M$89M$109M$110M$84M$98M$93M$97M$116M$112M$112MDepreciationDeprec.
$87M$73M($22M)($49M)($80M)$7M$39M($61M)($131M)$50M$50MWorking capital & otherWC & other
$76M$75M$119M$49M$37M$97M$191M$38M$39M$33M$33MCapexCapex
8.6%8.3%12.3%4.9%4.3%9.7%16.4%2.9%2.9%2.5%2.5%Capex / revenueCapex/rev
$84M$146M$40M$109M$72M$76M$180M$144M$142M$260M$260MOwner earningsOwner earn.
9.4%16.1%4.2%11.1%8.2%7.6%15.4%11.0%10.5%19.5%19.5%Owner earnings marginOE mgn
$84M$146M$40M$109M$72M$76M$82M$144M$142M$260M$260MFree cash flowFCF
9.4%16.1%4.2%11.1%8.2%7.6%7.0%11.0%10.5%19.5%19.5%Free cash flow marginFCF mgn
$435M$3M$3M$244M$151M$60M$60MAcquisitionsAcquis.
$0$100M$160M$175M$0$0$75M$0$225M$175MBuybacksBuybacks
-2%5%7%11%7%4%10%8%10%7%7%ROICROIC
-4%6%8%13%11%6%14%12%20%12%12%Return on equityROE
−4%6%8%13%11%6%14%12%20%12%12%Retained to equityRetained/eq
Balance sheet
$140M$180M$169M$137M$192M$259M$284M$179M$307M$245M$245MCash & investmentsCash+inv
$153M$151M$185M$165M$128M$159M$179M$207M$203M$217M$217MReceivablesReceiv.
$177M$161M$194M$270M$323M$293M$259M$317M$365M$306M$306MInventoryInvent.
$43M$55M$63M$51M$50M$58M$64M$73M$67M$51M$51MAccounts payablePayables
$287M$257M$316M$385M$400M$394M$375M$450M$501M$472M$472MOperating working capitalOper. WC
$510M$521M$576M$604M$694M$756M$770M$769M$935M$835M$835MCurrent assetsCur. assets
$211M$385M$236M$275M$253M$442M$252M$300M$578M$283M$283MCurrent liabilitiesCur. liab.
2.4×1.4×2.4×2.2×2.7×1.7×3.1×2.6×1.6×3.0×3.0×Current ratioCurr. ratio
$211M$211M$211M$211M$466M$467M$466M$565M$604M$656M$656MGoodwillGoodwill
$1.2B$1.2B$1.3B$1.3B$1.8B$1.9B$1.9B$2.2B$2.5B$2.4B$2.4BTotal assetsAssets
$315M$254M$350M$382M$708M$774M$766M$808M$1.2B$1.2B$1.2BTotal debtDebt
$175M$74M$181M$245M$515M$514M$481M$629M$918M$979M$979MNet debt / (cash)Net debt
$740M$752M$668M$587M$732M$749M$818M$960M$821M$796M$796MShareholders’ equityEquity
1.0%1.4%1.8%2.1%2.9%2.5%2.2%2.2%2.2%2.5%2.5%Stock comp / revenueSBC/rev
Per share
51.5M53.5M52.9M51.8M51.3M51.4M51.4M51.4M50.7M47.4M47.4MShares out (diluted)Shares
$17.20$16.90$18.28$19.08$16.97$19.34$22.73$25.47$26.82$28.17$28.17Revenue / shareRev/sh
$-0.51$0.85$1.04$1.48$1.55$0.84$2.24$2.29$3.31$2.05$2.05EPS (diluted)EPS
$1.62$2.72$0.76$2.11$1.40$1.48$3.50$2.79$2.81$5.50$5.50Owner earnings / shareOE/sh
$1.62$2.72$0.76$2.11$1.40$1.48$1.59$2.79$2.81$5.50$5.50Free cash flow / shareFCF/sh
$1.48$1.40$2.25$0.94$0.72$1.88$3.72$0.74$0.77$0.69$0.69Cap. spending / shareCapex/sh
$14.35$14.06$12.62$11.33$14.26$14.59$15.91$18.68$16.18$16.82$16.82Book value / shareBVPS
Per-share growththe realized rate an owner's share compounded
9-yr5-yr
Revenue / share+5.6%/yr+10.7%/yr
Owner earnings / share+14.5%/yr+31.5%/yr
EPS+5.8%/yr
Capital spending / share−8.1%/yr−0.8%/yr
Book value / share+1.8%/yr+3.3%/yr

The record, charted

FY2017–2026

Each measure over its full record; the current point and the worst year marked.

Share count
47Mpeak FY2018
ROIC
7%low FY2017
Gross margin
59%low FY2017
Net debt ÷ owner earnings
3.8×peak FY2021

Owner earnings vs. net income

Owner earningsNet income

The accountant's number, and the cash an owner can take; the gap is the tell.

$260Mowner earningsvs.$97Mnet incomelow FY2019

Where the cash went

ReinvestBuybacksDividendsAcquisitionsRetainedBeyond op. cash

Each year's outlays against its operating cash: the mix, and how it drifts. The hatched cap is spending beyond that year's operating cash — financed from the balance sheet or borrowing, not operations.

FY2017FY2026

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2026 the business turned $97M of profit into $260M of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.

Reported net income$97M
Owner earnings$260M · 20% of revenue
FY2026FY2025FY2024FY2023FY2022
Reported net income$97M$168M$118M$115M$43M
Depreciation & amortizationnon-cash charge added back+$112M+$116M+$97M+$93M+$98M
Stock-based compensationreal costnon-cash, but a real cost+$34M+$30M+$28M+$26M+$24M
Working capital & othertiming of cash in and out, other non-cash items+$50M−$131M−$61M+$39M+$7M
Cash from operations$293M$182M$182M$273M$172M
Maintenance capital expenditurethe spending needed just to hold position and volume−$33M−$39M−$38M−$93M−$97M
Owner earnings$260M$142M$144M$180M$76M
Growth capital expenditurediscretionary; spent to get bigger, not to stand still−$98M
Free cash flow$260M$142M$144M$82M$76M
Owner-earnings marginowner earnings ÷ revenue20%10%11%15%8%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $34M), owner earnings is nearer $227M.

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2026 10-K · source on SEC EDGAR →

Will it survive?

  • Comfortable
    Operating income $157M ÷ interest expense $6K
    What this means

    Operating profit covers interest with the kind of margin Graham wanted for a defensive holding. Necessary, not sufficient, it says solvent, not cheap.

  • How heavy is the debt, net of cash? $979M · 6.2× operating profit
    Heavy net debt
    Cash $245M − debt $1.2B
    What this means

    Netting $245M of cash and short-term investments against $1.2B of debt leaves $979M owed, about 6.2× a year's operating profit (7.8× on the gross debt, before the cash). Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Long (60+ days)
    DSO 59 + DIO 205 − DPO 34 days
    What this means

    Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.

Is it a good business?

  • Below average through the cycle
    10-yr median, range -2%–11%; 7% latest = NOPAT $119M ÷ invested capital $1.8B
    Industry peers: median -3%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 10 years (it ran 7% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • Solid through the cycle
    10-yr median margin, range 4%–20%; latest $260M = operating cash $293M − maintenance capex $33M
    Industry peers: median 1%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 20% of revenue this year, a 10% median across 10 years. Treating stock comp as the real expense it is (less $34M of SBC) leaves $227M.

  • Cash-backed
    Cash from ops $293M ÷ net income $97M
    What this means

    How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.

How is the cash used?

  • Returns about half
    Dividends + buybacks $175M ÷ Owner Earnings $260M
    What this means

    Of $260M Owner Earnings, $175M (67%) went back to shareholders, $0 dividends, $175M buybacks. Net of $34M stock comp, the real buyback was about $141M. Returning most of it is the mark of a mature business with little left to reinvest at a high return; reinvesting most could mean a long runway, or empire-building. The split doesn't say which; the return earned on it (see ROIC) does.

  • Investing or harvesting? 0.29×
    Harvesting
    Capex $33M ÷ depreciation $112M
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

Graham’s defensive tests · 2 of 6 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Near
    Revenue ≥ $2B · $1.3B
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Pass
    Current ratio ≥ 2× · 2.95×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Miss
    Debt ≤ working capital · $1.2B vs $552M WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Earnings stability Near
    A profit every year (10-yr record) · 1 loss year
    What this means

    Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.

  • Dividend record Miss
    Uninterrupted dividends · none paid
    What this means

    An unbroken dividend was Graham's mark of durability. He wanted twenty years; the filings show about ten, and a single suspension breaks the streak. Non-payers, many fine modern compounders, fall outside his defensive net by design.

  • Earnings growth Pass
    Earnings +33% over the record · +415%
    What this means

    At least a third more earnings than a decade ago, averaging three years at each end. Net income (not per-share), so stock splits don't distort it, buybacks and dilution show up in the share-count line instead.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $2.81/share (latest year $2.14), the averaged base the calculator's gate runs on, and book value is $17.52/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2017–2026

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 9 of 10
    What this means

    Lost money in 1 year(s), look at what happened there before trusting the average.

  • Return on capital ≥ 15% 0 of 10 yrs
    What this means

    A moat shows up as a high return on invested capital that holds year after year, not one good vintage.

  • Operating margin 4% → 14% (3-yr avg ends)
    What this means

    Through the cycle the operating margin widened — about 4% early to 14% lately, median 10% — pricing power intact or improving.

  • Reinvestment, incremental ROIC 13%
    What this means

    Reinvested capital came back at only a modest incremental return — near the cost of capital, where extra growth adds little per dollar. The record shows whether it is a soft stretch or a thinning moat.

  • Owner earnings growth +6%/yr
    What this means

    Owner earnings grew about 6% a year over the record.

  • Worst year 2017 · −2.2% op. margin
    What this means

    Operations went underwater in 2017, understand why before trusting the good years.

  • Share count −0.9%/yr
    What this means

    The share count is shrinking, buybacks are quietly growing your slice of the business.

Does AI threaten the moat?

Low contestability

The moat is physical, regulated or balance-sheet-funded, the kind AI cuts costs within but does not contest.

In its own filing Raised, but not as a competitor

The filing raises AI among its risks, but in other terms (security, regulation, energy or the like), not as a competitor to its product.

AI is unlikely to contest a moat that is physical, regulated or balance-sheet-funded; here it reads more as a cost tool than a threat.

Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.

All figures as filed; the source filing is linked above.

Current Position

as of fiscal year-end, Mar 28, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$835M
  • Cash & short-term investments$245M
  • Receivables$217M
  • Inventory$306M
  • Other current assets$66M
Current liabilities$283M
  • Debt due within a year$5M
  • Accounts payable$51M
  • Other current liabilities$227M
Current ratio2.95×all current assets ÷ what's due · Graham looked for 2×
Quick ratio1.87×stricter: inventory excluded
Cash ratio0.87×strictest: cash alone against what's due
Working capital$552Mthe cushion left after near-term bills
Debt due this year vs. cash$5M due · $245M cash covered by cash on hand, no refinancing forced · both figures from the Mar 28, 2026 balance sheet
Revenue, latest quarter vs. a year ago−2.7%the freshest read on whether the business is still growing
Current ratio, recent quarters3.8× → 3.0×
Deeper floors
Tangible book value($308M)equity stripped of goodwill & intangibles
Debt incl. operating leases$1.3B$50M of it operating leases
Deferred revenue$42Mcustomer cash collected before delivery; operating float

From the company's latest filing.

How the cash was used, 2017–2026

Over the record, the business generated $1.9B of operating cash; how management split it reads as a balanced allocator, splitting cash between the business, owners, and the balance sheet.

  • Reinvested$754M · 39%
  • Buybacks$910M · 48%
  • Retained (debt / cash)$245M · 13%
  • Returned to owners$910M

    73% of the owner earnings the business produced over the span, $0 as dividends and $910M as buybacks.

  • Source of fundingOperating cash

    Operating cash covered reinvestment and returns; over the span debt rose $910M and cash and short-term investments rose $106M.

  • Average price paid for buybacks$74.48

    Across the years where the filing reports a share count, 4M shares were bought for $300M, about $74.48 each.

  • Net change in share count−8.1%

    The diluted count fell from 52M to 47M, so the buybacks outran the stock issued to staff.

  • Dividend record

    No dividend line was reported in the filing data over the span; the record here neither confirms nor rules out a payout.

Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.

Acquisitions & goodwill

from the balance sheet & the 10-year cash-flow record

Goodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.

Goodwill & intangibles$1.1B46% of all assets; the premium carried on the balance sheet for businesses acquired
Against book equity82%goodwill is this share of book equity; the rest is the company’s own retained and paid-in capital
Cash spent acquiring$895Mover 10 years buying other businesses, against $754M of capital spent building

$57M written down across 1 year (2017): goodwill the company has already conceded it overpaid for, charged against earnings. A write-down costs no cash (the cash went out when the deal was signed), but it is management marking its own past judgment to market.

Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend and write-downs summed across the 10-year record, from the company's own filings.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.

Fiscal yearChief executivePay, as filed“Actually paid”Owner earnings
2022Christopher A. Simon$8.7M−$2.4M$76M
2023Christopher A. Simon$10.7M$18.1M$180M
2024Christopher A. Simon$11.5M$10.2M$144M
2025Christopher A. Simon$10.7M$1.3M$142M
2026Christopher A. Simon$12.0M$8.1M$260M

Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.

  • Insider ownership2.1%

    The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.

  • Stock-based compensation$34M

    The slice of the business handed to employees in shares this year, 3% of revenue, equal to 22% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

Inverting the record

Invert: instead of why Haemonetics is a good business, the question is what would make owning it a mistake, and whether those marks are in the record. Disconfirming tests across 2017–2026.

2 of the 6 tests turned up something to look into; the other 4 came back clean.

  • Look hereDid debt outgrow the business?$315M → $1.2B

    Debt rose from $315M to $1.2B while owner earnings went from about $90M to $182M — about 3.5 years of owner earnings in debt then, about 6.7 now: measured against what the business earns, the balance sheet carries more debt than it did. Debt raised for buybacks or deals rather than growth is the kind that bites in a downturn.

  • Look hereAre "one-time" charges a yearly habit?10 of 10 years

    Management took an impairment or write-down in 10 of the last 10 years, $337M in all. A charge taken almost every year is not one-time; it is the business — past deals coming due, and an admission the assets were worth less than what was paid. Munger's rule: when the "one-time" keeps happening, it is the business. Read it beside the goodwill the company still carries.

And these came back clean
  • Is it less profitable than it was?
  • Did the share count rise anyway?
  • Did reported profit become cash?
  • Did receivables and inventory outpace sales?

Each test is read from the filings and is noisy alone; a flag can mark a cyclical trough or a year of heavy investment as easily as a problem. The filing says which.

What an owner would ask, FY2026

read the 10-K →
  • Which reported numbers are a judgment call?
    Management names Revenue recognition, Income taxes, Acquisitions, Contingencies as critical estimates

    each rests partly on management's judgment; the filing's note sets out the assumptionsverify →

The questions the record and the charts do not answer on their own; each carries the figure and the place to look.

Peers, Medical Devices & Equipment

The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.

CompanyRevenueGross marginOp. marginROICOwner earn. margin
TFXTeleflex$2.0B55%16.6%7%13%
IARTIntegra Lifesciences Holdings Corp$1.6B62%7.4%4%8%
PENPenumbra$1.4B65%0.5%0%3%
HAEHaemonetics$1.3B50%10.4%7%11%
TNDMTandem Diabetes Care$1.0B52%-15.0%-24%-1%
INSPInspire Medical Systems$912M84%-28.7%-19%-23%
OFIXOrthofix Medical Inc. Common Stock (DE)$822M75%-2.3%-3%1%
ATECAlphatec Holdings$764M68%-30.2%-47%-31%
Group median63%-0.9%-1%2%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Haemonetics has delivered.

Haemonetics’s latest year runs above its own through-cycle margin — the reported figure may flatter a peak. So the tool opens on the through-cycle base, Graham’s averaging cutting both ways; clear the toggle below to read the latest year exactly as reported.

$

Through the cycle, Haemonetics earns about $143M on its 10.7% median owner-earnings margin. This year’s 19.5% margin runs above that; the reported figure may flatter a peak you'd be paying on. Normalize, below, values the price on that through-cycle figure rather than the latest year. It comes pre-checked here for that reason, the same rule that already normalizes a trough; clear it to price the year as filed.

Base

The assumptions

9.0% = the 4.55% 10-year Treasury (Jul 15, 2026) + 4.45 points of equity premium. The rate you require is yours to set.

Enter a price above to run it.

Implied by the price
Owner-earnings growth · ’22→’26+12%/yr
Owner-earnings growth · ’17→’26+6%/yr
Owner-earnings yield
P/E (3-yr earnings ’24–’26)
P/B
Graham’s price gate

Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.

Against a high-grade bond: Graham’s yardstick bond yield%

Prefilled with the 10-year Treasury (4.55%, as of Jul 15, 2026). Edit it for today’s exact figure, or a AAA corporate yield.

Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.

Owner earnings $260M on 45M shares outstanding, per the 10-K cover, as of 2026-05-15; net debt $979M. The if-converted diluted count is 47M, 4% above the shares outstanding: the dilution overhang (convertibles, options) a buyer inherits. The base opens on the through-cycle figure (the latest year sits above the record’s own median, and Graham’s averaging cuts both ways); clear Normalize to use the year as filed. Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.

Cite: Owner Scorecard, "Haemonetics (HAE), the owner's record," https://ownerscorecard.com/c/HAE, data as of 2026-07-09.

Manual order: ← H its page in the Manual HAFC →

Industry order: ← GMED the Medical Devices & Equipment chapter HOLX →